tiprankstipranks
Hangzhou Tigermed Consulting Co., Ltd. Class H (HK:3347)
:3347

Hangzhou Tigermed Consulting Co., Ltd. Class H (3347) Similar Stocks

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Hangzhou Tigermed Consulting Co., Ltd. Class H
HK$33.30
HK$44.07B
27.63
26.79%
0 Buy
0 Hold
0 Sell
Moderate Sell
Sino Biopharmaceutical
$0.43
$7.99B
22.29
12.63%
0 Buy
1 Hold
0 Sell
Hold
CSPC Pharmaceutical Group
$0.62
$7.19B
8.97
-17.33%
2 Buy
2 Hold
0 Sell
Moderate Buy
Livzon Pharmaceutical Group
$3.27
$3.88B
10.75
-10.16%
0 Buy
0 Hold
0 Sell
Moderate Sell
Shanghai Fosun Pharmaceutical (Group) Co
$2.01
$8.41B
18.26
6.91%
0 Buy
1 Hold
0 Sell
Hold
Wuxi Biologics (Cayman)
$2.80
$12.45B
32.04
24.44%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:3347
Hangzhou Tigermed Consulting Co., Ltd. Class H
33.10
7.24
28.00%
SBMFF
Sino Biopharmaceutical
0.43
0.05
13.16%
CHJTF
CSPC Pharmaceutical Group
0.62
-0.15
-19.48%
LVZPF
Livzon Pharmaceutical Group
3.27
-0.33
-9.17%
SFOSF
Shanghai Fosun Pharmaceutical (Group) Co
2.01
0.11
5.79%
WXIBF
Wuxi Biologics (Cayman)
2.80
0.56
25.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis